Total Payments
$7,967
2024 Payments
$1,404
Companies
47
Transactions
356
Medicare Patients
8,296
Medicare Billing
$608,393
Payment Breakdown by Category
Food & Beverage$7,296 (91.6%)
Education$670.69 (8.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,296 | 341 | 91.6% |
| Education | $670.69 | 15 | 8.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,642 | 69 | $0 (2024) |
| Janssen Biotech, Inc. | $1,169 | 38 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $503.86 | 14 | $0 (2024) |
| Boston Scientific Corporation | $441.28 | 18 | $0 (2024) |
| PFIZER INC. | $402.79 | 16 | $0 (2024) |
| ABBVIE INC. | $402.19 | 21 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $377.35 | 17 | $0 (2024) |
| Allergan, Inc. | $268.13 | 18 | $0 (2020) |
| Ferring Pharmaceuticals Inc. | $226.98 | 15 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $224.16 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,404 | 55 | Sumitomo Pharma America, Inc. ($272.49) |
| 2023 | $1,744 | 63 | Astellas Pharma US Inc ($245.14) |
| 2022 | $352.43 | 16 | Rochester Medical Corporation ($127.42) |
| 2020 | $342.04 | 17 | Astellas Pharma US Inc ($152.10) |
| 2019 | $1,513 | 76 | Astellas Pharma US Inc ($335.58) |
| 2018 | $1,538 | 72 | Astellas Pharma US Inc ($416.43) |
| 2017 | $1,073 | 57 | Astellas Pharma US Inc ($287.26) |
All Payment Transactions
356 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | 180 Medical, Inc. | CURE CATHETER (Device) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: CONTINENCE CARE | ||||||
| 10/22/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Oncology | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Boston Scientific Corporation | Moses 550 DFL (Device) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Moses 550 DFL_URO | ||||||
| 10/02/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Oncology | ||||||
| 10/02/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $14.28 | General |
| Category: ONCOLOGY | ||||||
| 09/23/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: HORMONE THERAPY | ||||||
| 09/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: Oncology | ||||||
| 09/17/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $105.16 | General |
| Category: UROLOGY | ||||||
| 08/22/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: ONCOLOGY | ||||||
| 08/19/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Oncology | ||||||
| 08/15/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $20.02 | General |
| Category: Prostate cancer | ||||||
| 08/08/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Oncology | ||||||
| 08/01/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $41.55 | General |
| Category: Urology | ||||||
| 07/31/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $19.49 | General |
| Category: ONCOLOGY | ||||||
| 07/26/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Oncology | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Oncology | ||||||
| 07/11/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: ONCOLOGY | ||||||
| 07/03/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: LithoVue_URO | ||||||
| 07/03/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: rezum_URO | ||||||
| 06/24/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,991 | 7,299 | $570,250 | $152,984 |
| 2022 | 26 | 2,052 | 9,923 | $610,642 | $162,772 |
| 2021 | 25 | 2,313 | 3,407 | $567,474 | $155,720 |
| 2020 | 27 | 1,940 | 4,301 | $478,928 | $136,917 |
Total Patients
8,296
Total Services
24,930
Medicare Billing
$608,393
Procedure Codes
102
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 303 | 437 | $142,025 | $39,566 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 317 | 431 | $99,561 | $26,173 | 26.3% |
| J9155 | Injection, degarelix, 1 mg | Office | 2023 | 15 | 4,483 | $33,623 | $13,920 | 41.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 113 | 113 | $47,912 | $13,386 | 27.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 73 | 79 | $50,007 | $12,871 | 25.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 14 | 78 | $38,064 | $10,628 | 27.9% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 19 | 20 | $26,400 | $6,827 | 25.9% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 22 | 22 | $18,282 | $4,925 | 26.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 116 | 126 | $18,144 | $4,402 | 24.3% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 21 | 22 | $11,050 | $2,446 | 22.1% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 15 | 15 | $9,375 | $2,424 | 25.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 24 | $8,136 | $2,343 | 28.8% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 354 | 561 | $14,025 | $2,210 | 15.8% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 23 | 41 | $8,200 | $1,894 | 23.1% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 24 | 73 | $7,300 | $1,771 | 24.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 179 | 216 | $11,880 | $1,619 | 13.6% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 111 | 166 | $5,810 | $1,305 | 22.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 12 | 12 | $6,348 | $1,274 | 20.1% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2023 | 64 | 94 | $3,290 | $751.20 | 22.8% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 59 | 88 | $3,520 | $738.98 | 21.0% |
| 87088 | Bacterial urine culture | Office | 2023 | 63 | 93 | $3,255 | $737.23 | 22.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 68 | $3,536 | $675.80 | 19.1% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2023 | 14 | 23 | $157.50 | $49.12 | 31.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 12 | 14 | $350.00 | $47.74 | 13.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 354 | 539 | $124,509 | $32,462 | 26.1% |
About Dr. Jaffer Bashey, M.D
Dr. Jaffer Bashey, M.D is a Urology healthcare provider based in Dubuque, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801820139.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jaffer Bashey, M.D has received a total of $7,967 in payments from pharmaceutical and medical device companies, with $1,404 received in 2024. These payments were reported across 356 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($7,296).
As a Medicare-enrolled provider, Bashey has provided services to 8,296 Medicare beneficiaries, totaling 24,930 services with total Medicare billing of $608,393. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Dubuque, IA
- Active Since 07/11/2006
- Last Updated 12/09/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1801820139
Products in Payments
- XTANDI (Drug) $877.76
- Erleada (Drug) $616.00
- Myrbetriq (Drug) $454.92
- PROVENGE (Drug) $377.35
- ZYTIGA (Drug) $376.09
- ERLEADA (Drug) $305.48
- GEMTESA (Drug) $295.60
- BOTOX (Biological) $281.95
- MYRBETRIQ (Drug) $271.53
- ELIGARD (Drug) $253.55
- ORGOVYX (Drug) $245.99
- REZUM (Device) $173.17
- LYNPARZA (Drug) $166.75
- GREENLIGHT (Device) $145.47
- BOTOX THERAPEUTIC (Biological) $137.82
- FIRMAGON (Drug) $136.00
- CAMCEVI (Drug) $131.21
- CURE CATHETER (Device) $113.83
- Nubeqa (Drug) $112.26
- Xofigo (Drug) $111.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Dubuque
Dr. Alex Horchak, M.d, M.D
Urology — Payments: $12,993
Urology $12,993
Raymond Roewe
Urology — Payments: $4,529
Urology $4,529
John Dolehide, D.o, D.O
Urology — Payments: $4,336
Urology $4,336
Dr. James Voelker, M.d, M.D
Urology — Payments: $14.35
Urology $14.35
George Kraemer, M.d, M.D
Urology
Urology